# Extended Release Protein Dosing

> **NCT07313436** · NA · ACTIVE_NOT_RECRUITING · sponsor: **VitaKey Inc.** · enrollment: 21 (estimated)

## Conditions studied

- Nutrition

## Interventions

- **OTHER:** Extended release nutritional protein
- **OTHER:** Control
- **OTHER:** Negative Dose

## Key facts

- **NCT ID:** NCT07313436
- **Lead sponsor:** VitaKey Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-11-17
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07313436

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07313436, "Extended Release Protein Dosing". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07313436. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*